|
1.
|
|
12 p, 639.3 KB |
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
/
Kanis, John A. (Australian Catholic University. Mary McKillop Health Institute) ;
Harvey, N. C. (University of Southampton. MRC Lifecourse Epidemiology Unit) ;
McCloskey, Eugene (MRC and Arthritis Research UK Centre for Integrated Research in Musculoskeletal Ageing Mellanby) ;
Bruyère, Olivier (University of Liège. World Health Organization Collaborating Center for the Public Health Aspects of Musculoskeletal Health and Aging, Department of Public Health, Epidemiology and Health Economics) ;
Veronese, Nicola (Neuroscience Institute (Pàdua, Itàlia). Aging Branch) ;
Lorentzon, Mattias (Sahlgrenska University Hospital (Suècia)) ;
Cooper, Cyrus (University of Oxford. NIHR Musculoskeletal Biomedical Research Unit) ;
Rizzoli, Rene (Geneva University Hospitals (Suïssa)) ;
Adib, Gemma (Syrian National Osteoporosis Society) ;
Al-Daghri, Nasser (King Saud University. Chair for Biomarkers of Chronic Diseases, Biochemistry Dept., College of Science) ;
Campusano, C. (Universidad de los Andes. Clinica Universidad de los Andes and Faculty of Medicine) ;
Chandran, Manju (Singapore General Hospital, ACADEMIA. Osteoporosis and Bone Metabolism Unit, Department of Endocrinology) ;
Dawson-Hughes, Bess (Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University) ;
Javaid, K. (University of Oxford. NIHR Musculoskeletal Biomedical Research Unit) ;
Jiwa, Famida (Osteoporosis Canada. Chair of the Committee of Patients Societies at the International Osteoporosis Foundation) ;
Johansson, H. (Australian Catholic University. Mary McKillop Health Institute) ;
Lee, J. K. (Beacon International Specialist Centre, Petaling Jaya, Malaysia) ;
Liu, Emilia (Australian Catholic University. Mary McKillop Health Institute) ;
Messina, Osvaldo D. (Cosme Argerich. IRO Medical Research Center, Buenos Aires and Rheumatology section) ;
Mkinsi, Ouafa (Ibn Rochd University Hospital. Department of Rheumatology) ;
Pinto, Daniel (Northwestern University. Department of Medical Social Sciences, Feinberg School of Medicine) ;
Prieto-Alhambra, Daniel (Universitat Autònoma de Barcelona) ;
Saag, Kenneth G (University of Alabama at Birmingham) ;
Xia, W. (Chinese Academy of Medical Sciences & Peking Union Medical College. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital) ;
Zakraoui, Leith (University Tunis Manar and Hôpital Mongi-Slim. Service de Rhumatologie) ;
Reginster, Jean-Yves (University of Liège. Department of Public Health, Epidemiology and Health Economics)
Guidance is provided in an international setting on the assessment and specific treatment of postmenopausal women at low, high and very high risk of fragility fractures. The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2019. [...]
2020 -  10.1007/s00198-019-05176-3
Osteoporosis International, Vol. 31 (2020) , p. 1-12
|
|
|
2.
|
|
15 p, 1.0 MB |
Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength : state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
/
Díez Pérez, Adolfo (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Brandi, Maria Luisa (University of Florence. Department of Biological, Experimental and Clinical Science) ;
Al-Daghri, Nasser (King Saud University. Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science) ;
Branco, Jaime (Universidade Nova de Lisboa. NOVA Medical School) ;
Bruyère, Olivier (Université de Liège) ;
Cavalli, Loredana (University of Florence. Department of Biological, Experimental and Clinical Science) ;
Cooper, Cyrus (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Cortet, Bernard (University Hospital of Lille (França)) ;
Dawson-Hughes, Bess (Tufts University. Bone Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging) ;
Dimai, Hans Peter (Medical University of Graz. Department of Internal Medicine, Division of Endocrinology and Diabetology) ;
Gonnelli, Stefano (University of Siena. Department of Medicine, Surgery and Neurosciences) ;
Hadji, Peyman (Frankfurter Hormon und Osteoporose Zentrum, Frankfurt, Germany) ;
Halbout, Philippe (International Osteoporosis Foundation, Nyon, Switzerland) ;
Kaufman, Jean-Marc (Universitair Ziekenhuis Gent) ;
Kurth, Andreas (Mayor Teaching Hospital, Charite Medical School) ;
Locquet, Medea (University of Liège. Department of Public Health, Epidemiology and Health Economics) ;
Maggi, Stefania (Institute of Neuroscience. National Research Council, Aging Program) ;
Matijevic, Radmila (Clinical Center of Vojvodina, Clinic for Orthopedic Surgery) ;
Reginster, Jean-Yves (Université de Liège) ;
Rizzoli, René (Geneva University Hospitals (Suïssa)) ;
Thierry, Thomas (University of Lyon. INSERM 1059)
The purpose of this paper was to review the available approaches for bone strength assessment, osteoporosis diagnosis and fracture risk prediction, and to provide insights into radiofrequency echographic multi spectrometry (REMS), a non-ionizing axial skeleton technique. [...]
2019 - 10.1007/s40520-019-01294-4
Aging Clinical and Experimental Research, Vol. 31 (august 2019) , p. 1375-1389
|
|
|
3.
|
|
12 p, 675.8 KB |
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer : Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
/
Hadji, Peyman (Krankenhaus Nordwest) ;
Aapro, Matti S. (Genolier Cancer Center, Switzerland) ;
Body, Jean-Jacques (CHU Brugmann, Université Libre de Bruxelles, Belgium) ;
Gnant, Michael (Medical University of Vienna, Austria) ;
Brandi, Maria Luisa (University of Florence, Italy) ;
Reginster, Jean-Yves (University of Liège, Belgium) ;
Zillikens, M. Carola (Erasmus MC, Rotterdam, Netherlands) ;
Glüer, Claus-C. (Univeristy of Kiel, Germany) ;
de Villiers, Tobie (University of Stellenbosch, Cape Town, South Africa) ;
Baber, Rod (University of Sydney, Australia) ;
Roodman, G. David (Indiana University School of Medicine, USA) ;
Cooper, Cyrus (University of Southampton, UK) ;
Langdahl, Bente (Aarhus University, Denmark) ;
Palacios, Santiago (Instituto Palacios. Salud y Medicina de la Mujer (Madrid, Espanya)) ;
Kanis, John (Catholic University of Australia, Melbourne, Australia and University of Sheffield, UK) ;
Al-Daghri, Nasser (University of Riyadh, Saudi Arabia) ;
Nogués Solán, Xavier (Universitat Autònoma de Barcelona) ;
Eriksen, Erik Fink (University of Oslo, Norway) ;
Kurth, Andreas (Klinikum Birkenwerder, Germany) ;
Rizzoli, Rene (Geneva University, Switzerland) ;
Coleman, Robert E. (University of Sheffield, UK)
Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor (AI) therapy. Recently, a number of studies on additional fracture related risk factors, new treatment options as well as real world studies demonstrating a much higher fracture rate than suggested by randomized clinical controlled trials (RCTs). [...]
2017 - 10.1016/j.jbo.2017.03.001
Journal of Bone Oncology, Vol. 7 (June 2017) , p. 1-12
|
|
|
4.
|
|
11 p, 634.6 KB |
Diacerein : Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
/
Pavelka, Karel (Charles University) ;
Bruyère, Olivier (Liège, Belgium) ;
Cooper, Cyrus (Southampton, UK) ;
Kanis, John A. (Sheffield, UK) ;
Leeb, Burkhard F. (State Hospital Stockerau) ;
Maheu, Emmanuel (St-Antoine Hospital) ;
Martel-Pelletier, Johanne ;
Monfort, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Pelletier, Jean-Pierre (University of Montreal Hospital Research Centre (CRCHUM)) ;
Rizzoli, René (Geneva University Hospitals (Suïssa)) ;
Reginster, Jean-Yves (Université de Liège) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. [...]
2016 - 10.1007/s40266-016-0347-4
Drugs & Aging, Vol. 33 (february 2016) , p. 75-85
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
